8-K: Qrons Inc. to Merge with First Person Ltd. in Stock Deal

Qrons Inc. announces a merger agreement with First Person Ltd., a Canadian corporation focused on cognitive performance products, through a stock issuance.

Summary

• Qrons Inc. has entered into a merger agreement with First Person Ltd., a Canadian corporation specializing in cognitive performance products.
• The merger will occur through a wholly-owned subsidiary of Qrons, Primary Merger Sub, Inc., merging into First Person, with First Person becoming a wholly-owned subsidiary of Qrons.
• Qrons will issue 8,000 shares of its newly designated Series B Convertible Preferred Stock to First Person's shareholders.
• The merger is expected to close on or before January 20, 2025, pending certain conditions.
• These conditions include First Person securing $250,000 in funding commitments, Qrons entering into an anti-dilution agreement, and the consummation of a stock purchase agreement.
• Qrons filed an amendment to its Articles of Incorporation on January 2, 2025, to restate the Series A Preferred Stock and establish the Series B Convertible Preferred Stock.
• The Series B Preferred Stock grants holders a total of 99,943,448 votes and will be automatically converted into common stock upon increasing the number of authorized shares of Common Stock to no fewer than 500,000,000 shares.
• The conversion rate is 12,492.931 shares of Common Stock for each one (1) share of Series B Preferred Stock.
• The company's management anticipates no obstacles to the merger's completion.

Sentiment

Score: 7

Explanation: The document conveys a moderately positive sentiment due to the strategic merger announcement and management's confidence. However, the reliance on First Person securing funding and potential dilution temper the overall optimism.

Positives

• The merger allows Qrons to expand into the cognitive performance market through First Person's existing product platform.
• The anti-dilution agreement protects existing shareholders from dilution for a specified period.
• Management expresses confidence in the successful completion of the merger.

Negatives

• The merger is contingent on First Person securing $250,000 in funding commitments, which introduces uncertainty.
• Existing Qrons shareholders will experience dilution upon conversion of the Series B Preferred Stock into common stock.
• Qrons' common stock trades on the OTC Markets OTCQB platform, which may be less liquid and more volatile than major exchanges.

Risks

• Failure to secure the required $250,000 funding for First Person could jeopardize the merger.
• The accuracy of representations and warranties made by both parties is crucial, as they do not survive the merger's consummation.
• Material adverse changes in either company's condition could prevent the merger from closing.
• The market for cognitive performance products is competitive and subject to changing consumer preferences.
• The company needs to increase the number of authorized shares of Common Stock to no fewer than 500,000,000 shares to enable the conversion of the Series B Preferred Stock.

Future Outlook

The company anticipates the merger will be completed successfully, expanding its business into the cognitive performance market.

Management Comments

• The Company's management sees no impediment to the consummation of the Merger.

Industry Context

The cognitive performance market is experiencing growth, driven by increasing consumer interest in products that enhance focus, memory, and overall brain function. This merger positions Qrons to capitalize on this trend.

Comparison to Industry Standards

• It is difficult to compare this merger to industry standards without knowing the specific financial details of First Person Ltd.
• However, similar acquisitions in the consumer health and wellness space often involve multiples of revenue or EBITDA.
• The success of the merger will depend on First Person's ability to scale its operations and integrate effectively with Qrons.

Management Changes

Stakeholder Impact

• Shareholders of Qrons will experience dilution upon conversion of the Series B Preferred Stock.
• Employees of both companies may experience changes in roles and responsibilities.
• Customers of First Person Ltd. will gain access to a broader range of resources and potentially new products.
• The merger could impact suppliers and creditors of both companies, depending on integration strategies.

Next Steps

• First Person Ltd. needs to secure $250,000 in funding commitments.
• Qrons Inc. needs to enter into an anti-dilution agreement with certain affiliates.
• A stock purchase agreement relating to the sale of all outstanding shares of the Company's Series A Preferred Stock needs to be consummated.
• Shareholder approval from both companies is required.
• The companies need to file Articles of Merger/Articles of Amalgamation with the relevant authorities.
• Qrons needs to increase the number of authorized shares of Common Stock to no fewer than 500,000,000 shares.

Key Dates